| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/19/2006 | CN1264550C Chinese medicine resina draconis extract preparing method |
| 07/19/2006 | CN1264548C Moutan bark and leech-containing capsule for lowering blood sugar and its preparation method |
| 07/19/2006 | CN1264525C Chinese medicine for treating diabetes |
| 07/19/2006 | CN1264519C Notoginseng total saponin amino acid transfusion liquid and its producing method |
| 07/19/2006 | CN1264511C Preparation and use of extracting protopine from plant |
| 07/19/2006 | CN1264500C Fat milk transfusion fluid for treating pulmonary heart disease and energy supplement and its producing method |
| 07/19/2006 | CN1264430C Nucleotide and amino acid nutrient products and their production |
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078558 Salt formated crystal for treating hypercholesterolemia and hyperlipidemia; anticholesterol agents, antilipemic agents |
| 07/18/2006 | US7078522 2-heterocycle-7-oxo-pyrido-[2,3-d]-pyrimidines or 2-oxo-7-heterocycle-1,6-naphthyridines; phosphodiesterase V inhibitors; erectile dysfunction; side effect reduction |
| 07/18/2006 | US7078430 3-carbamoyl-pyran that is n-derivatized by dihydroxyheptanoic acid or 6-ethyl-4-hydroxy-pyran-2-one; anticholesterol agents |
| 07/18/2006 | US7078425 4-(2-substituted aminocarbonyl-2-substituted aminoethyl)-7-carboxymethoxy- indole, indazole, indoline, benzotriazole or benzoimidazole derivatives, e.g., 4-[2-Benzenesulfonylamino-2-(4-phenyl-butylcarbamoyl)-ethyl]-1H-indazol-7-yloxy}-acetic acid; treating or preventing Type II Diabetes Mellitus |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078422 Activator for peroxisome proliferator-activated receptor |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078410 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 07/18/2006 | US7078407 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078397 Comprises thiadiazolidinedione-based insulin sensitizers (troglitazone); peroxisome proliferator-activated receptors |
| 07/18/2006 | US7078231 Human pancreatic progenitor cells for use in cell therapy |
| 07/18/2006 | US7078178 Identifying modulators of transmembrane calcium transfer; for treating bone, cancer and blood disorders |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078052 Enhanced absorption and bioavailability |
| 07/18/2006 | US7078048 A topical formulation for treating rosacea ( a facial dermatitis ) contains a combination of: an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14 |
| 07/18/2006 | US7078036 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 07/18/2006 | CA2407416C Alkynyl phenyl heteroaromatic glucokinase activators |
| 07/18/2006 | CA2216592C Benzothiophene compounds, intermediates, compositions, and methods |
| 07/13/2006 | WO2006074330A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/13/2006 | WO2006074244A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/13/2006 | WO2006074228A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 07/13/2006 | WO2006073772A1 Polyethylene glycol linked mc4r or mc3r agonist peptides |
| 07/13/2006 | WO2006073508A1 Use of il-22 for the treatment of conditions of metabolic disorders |
| 07/13/2006 | WO2006073367A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators |
| 07/13/2006 | WO2006073366A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073365A1 Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073364A1 Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073363A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073147A1 Remedial agent for fat toxicity |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072881A1 Methods and compositions for treating diabetes, metabolic syndrome and other conditions |
| 07/13/2006 | WO2006072832A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 07/13/2006 | WO2006072643A1 Compositions comprising natural products for the treatment of diabetes |
| 07/13/2006 | WO2006072354A1 Squaric acid derivatives |
| 07/13/2006 | WO2006072252A1 Preparation for preventing or treating calcium deficiency conditions in mammals |
| 07/13/2006 | WO2006072172A1 Compounds and methods for regulating triglyceride levels |
| 07/13/2006 | WO2006072171A1 Method for blood glucose control in a mammal by n-acylated glucosamines |
| 07/13/2006 | WO2006029577A8 Methods and compositions for the treatment of hyperlipidemia |
| 07/13/2006 | WO2006023515A3 Novel thiazole inhibitors of fructose 1,6-bisphosphatase |
| 07/13/2006 | WO2006013095A3 Condensed pyridines as kinase inhibitors |
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | WO2005110413A3 Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
| 07/13/2006 | WO2005077416A3 Lipid rafts and clostridial toxins |
| 07/13/2006 | US20060155111 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 07/13/2006 | US20060154979 Use of alpha-phenylthiocarboxylic and alpha-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154976 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 07/13/2006 | US20060154972 Amino acids with affinity for the alpha-2-delta-protein |
| 07/13/2006 | US20060154969 Adenosine receptor selective modulators |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents |
| 07/13/2006 | US20060154876 Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 07/13/2006 | US20060153842 Immunosuppressive combination and its use in the treatment or prophylaxis or insulin-producing cell graft rejection |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153825 Use of protein histidine phosphatase |
| 07/13/2006 | US20060153806 Proteins involved in the regulation of energy homeostasis |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | DE102004063494A1 Antikörper Antibody |
| 07/13/2006 | CA2830842A1 Method for producing probiotically derived compounds |
| 07/13/2006 | CA2594433A1 Compositions comprising the 2s,4r ketoconazole enantiomer for treating diabetes, metabolic syndrome and other conditions |
| 07/13/2006 | CA2594404A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | CA2594388A1 Squaric acid derivatives |
| 07/13/2006 | CA2594233A1 Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 07/13/2006 | CA2594116A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/13/2006 | CA2594098A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/13/2006 | CA2594023A1 Igf-i fusion polypeptides and therapeutic uses thereof |
| 07/13/2006 | CA2593793A1 Compounds and methods for regulating triglyceride levels |
| 07/13/2006 | CA2593768A1 Use of .omega.3 unsaturated fatty acids for relieving lipotoxicity |
| 07/13/2006 | CA2593549A1 Regeneration of pancreatic islets by amniotic fluid stem cell therapy |
| 07/13/2006 | CA2593432A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 07/13/2006 | CA2593394A1 Preparation for preventing or treating calcium deficiency conditions in mammals |
| 07/13/2006 | CA2593098A1 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 07/13/2006 | CA2592943A1 Use of il-22 for the treatment of conditions of metabolic disorders |
| 07/13/2006 | CA2592771A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 07/13/2006 | CA2585733A1 Adiponectin variants |
| 07/12/2006 | EP1679316A1 Stable vitamin b6 derivative |
| 07/12/2006 | EP1679310A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 07/12/2006 | EP1679068A1 Composition functioning to prevent or mitigate symptom or disease attributable to blood vessel aging |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1516866B1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 07/12/2006 | EP1509239A4 Composition and method for reducing post-prandial blood glucose |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | EP1392311B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 07/12/2006 | EP1303499B1 Tetrazole derivatives |
| 07/12/2006 | EP1015002B1 Aluminium free mixed metal compounds as phosphate binders |
| 07/12/2006 | CN1802386A GLP-1 analog fusion plroteins |